Brief: Saladax Biomedical And Hls Therapeutics Strengthen Partnership With An Exclusive Distribution Agreement For Canada
18/11/2021 18:29
HLS Therapeutics Inc HLS.TO :
* SALADAX BIOMEDICAL AND HLS THERAPEUTICS STRENGTHEN
PARTNERSHIP
WITH AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR CANADA
Source text for Eikon: ID:nBw6bVf7za
Further company coverage: HLS.TO
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease